The chemistry of creativity
Senior Madison Wang blends science, history, and art to probe how the world works and the tools we use to explore and understand it.
Senior Madison Wang blends science, history, and art to probe how the world works and the tools we use to explore and understand it.
The 17-year-old student from Spain uses MIT resources to deepen her understanding of math and physics.
The senior, majoring in electrical engineering and computer science, has participated in SuperUROP, NEET, MISTI GTL, and multiple labs focusing on biological EECS.
By changing how atoms in a molecule are arranged relative to each other, Associate Professor Alison Wendlandt aims to create compounds with new chemical properties.
Associate Professor Dwai Banerjee examines topics ranging from cancer care to the history of computing.
Associate Professor Evelina Fedorenko is working to decipher the internal structure and functions of the brain’s language-processing machinery.
Ana Trišović, who studies the democratization of AI, reflects on a career path that she began as a student downloading free MIT resources in Serbia.
MIT Sloan’s Christopher Palmer has produced new insights about household finance, thanks to razor-sharp empirical studies.
By studying cellular enzymes that perform difficult reactions, MIT chemist Dan Suess hopes to find new solutions to global energy challenges.
Stuart Levine ’97, director of MIT’s BioMicro Center, keeps departmental researchers at the forefront of systems biology.
Philosopher Kevin Dorst’s work examines how we apply rational thought to everyday life.
Zoe Fisher, a doctoral student in NSE, is researching how defects can alter the fundamental properties of ceramics upon radiation.
Graduate student and MathWorks Fellow Louis DeRidder is developing a device to make chemotherapy dosing more accurate for individual patients.
The chief of clinical quality and patient safety at MIT Health says her job allows her to use her entire skill set.
Stefani Spranger is working to discover why some cancers don’t respond to immunotherapy, in hopes of making them more vulnerable to it.